A study on mice suggests that stopping alcohol use can change brain activity in a way that might increase the risk of compulsive drinking later. Researchers found that a period of abstinence can lead to changes in a brain region called the bed nucleus of the stria terminalis (BNST), which is involved in responses to stress and negative emotions. These changes may make individuals more likely to drink despite the negative consequences, such as health risks or unpleasant tastes. The study involved mice that had long-term access to alcohol, followed by a forced period of abstinence. Some of these mice began drinking even when the alcohol was made bitter with quinine, a substance that typically deters drinking. These mice consumed more of the bitter alcohol compared to those that had not been abstinent. This suggests that abstinence might trigger brain changes that make relapse more likely, even when alcohol is less appealing. The researchers focused on the BNST, a small brain structure known to be involved in emotional responses and behaviors related to addiction. They found that when mice that had been abstinent were placed in an environment where they had previously drunk alcohol, they attempted to drink, even though the device only had water. This behavior was linked to increased activity in the BNST. Mice that had developed a preference for bitter alcohol showed more than double the BNST activity compared to those without a forced abstinence period. Importantly, this increased BNST activity was observed even before the mice were given access to alcohol, suggesting that it might be a biological marker for relapse risk. If similar findings are seen in humans, it could lead to new methods for identifying people who are at risk of relapse after stopping drinking. This could help clinicians provide more targeted and effective treatment strategies. Alcohol use disorders remain a major public health issue, with significant health and social consequences. In the United States, alcohol-related deaths in 2024 were more than four times higher than those from opioid use. Despite this, many people underestimate the risks of alcohol consumption. In the U.S., over 80% of people aged 12 and older consume alcohol in their lifetime, and about 10% develop an alcohol use disorder, affecting nearly 30 million people. In Europe, alcohol is responsible for more than 7% of diseases and premature deaths. Currently, there are limited tools to predict which individuals might benefit from treatment. While FDA-approved treatments exist, the number of diagnosed cases has nearly doubled in the U.S. since 1999. Developing better methods to identify people at risk and guide them toward appropriate therapies is crucial for improving outcomes. The role of the BNST in alcohol-related behaviors is still being studied. Researchers are trying to understand what causes the increase in BNST activity and which specific brain cells are involved. New neuroscience tools now allow scientists to manipulate specific neurons in mice, helping to uncover the BNST's role in compulsive drinking. Meanwhile, other researchers are examining BNST activity in humans undergoing early abstinence. If similar patterns are found, it could pave the way for clinical trials exploring the use of BNST activity as a screening tool for relapse risk.